Psychiatry & Neurology Doctors in Crystal, MN Accepting Medicare

4 Psychiatry & Neurology doctors found. Showing 1 - 4

Esther Aba Amokuma Yankey, APRN-PMHNP Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 5700 Bottineau Blvd Ste 210, Crystal, MN 55429 Phone: 763-330-2774

Dr. William George Nelson, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2960 Winnetka Ave N, Ste 208, Crystal, MN 55427 Phone: 763-512-1090    Fax: 763-512-1081

Dr. John Cooke Kluznik, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2960 Winnetka Ave N, Suite 208, Crystal, MN 55427 Phone: 763-512-1090

Pastor Colon, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2960 Winnetka Ave N, Suite 208, Crystal, MN 55427 Phone: 763-512-1090

News Archive

Global Fund to transfer management of HIV/AIDS grant in Mali after investigation finds misuse of funds

"The Global Fund to Fight AIDS, Tuberculosis and Malaria will transfer management of a $28.77 million HIV/AIDS grant from Mali's national AIDS council, the Haut Conseil de Lutte contre le Sida (the High Council for the Fight Against AIDS, or HCLNS), to a new principal recipient at the end of the year" after mismanagement of funds was discovered in the country, a Global Fund press release reports.

Extensive genomic, transcriptional diversity identified through massively parallel DNA and RNA sequencing

In a paper published in the online edition of Nature Genetics on July 3, 2011, sequencing specialists at Axeq Technologies, and scientists from Macrogen Inc., Genomic Medicine Institute at Seoul National University, Psoma Therapeutics Inc., Brigham and Women's Hospital and Harvard Medical School reported the discovery of a wide range of novel genetic variants based on the deep sequencing of 18 genomes and 17 transcriptomes of unrelated Korean individuals.

Nearly all women treated for breast cancer suffer from health problems, finds study

Nearly all women who have been treated for non-metastatic breast cancer suffer from health problems after primary treatment.

Atezolizumab may change treatment strategies for refractory lung cancer patients

Atezolizumab is set to substantially change treatment strategies for patients with refractory lung cancer, according to Dr Martin Reck, Chief Oncology Physician in the Department of Thoracic Oncology, Hospital Grosshansdorf, Germany. Reck's comments came as the results from the POPLAR and BIRCH studies showing the first results of efficacy with atezolizumab across lines were presented at the European Cancer Congress 2015 (ECC 2015) in Vienna, Austria.

Future of biomedical innovation depends on new trend for all players to work together for common goal

It's a long, expensive, risky road to turn a scientific breakthrough into a treatment that can help patients. Fewer organizations are trying to tackle the challenges alone, says a new paper from MIT researchers published August 28 in the journal Science Translational Medicine.

Read more Medical News

› Verified 8 days ago